In MASLD, FPR2 has been shown to protect from lipotoxicity and suppress MASLD progression in mice fed a choline-deficient, L-amino acid-defined high-fat diet [194]. The gene discussed is FPR2; the disease is metabolic dysfunction-associated steatotic liver disease.